Furthermore, human variants in antiviral ISG effector proteins, including MxA, OAS1 and IFITM3, have been shown to reduce the antiviral control of emerging pandemic viruses, specifically influenza (MxA and IFITM3) or SARS-CoV-2 (OAS1)10–12. The gene discussed is IFITM3; the disease is influenza.